0001764013-21-000041.txt : 20210323
0001764013-21-000041.hdr.sgml : 20210323
20210323085015
ACCESSION NUMBER: 0001764013-21-000041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210319
FILED AS OF DATE: 20210323
DATE AS OF CHANGE: 20210323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fromkin Andrew J.
CENTRAL INDEX KEY: 0001341896
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38906
FILM NUMBER: 21763263
MAIL ADDRESS:
STREET 1: C/O RADIUS HEALTH, INC.
STREET 2: 201 BROADWAY, 6TH FL
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER NAME:
FORMER CONFORMED NAME: Fromkin Drew J
DATE OF NAME CHANGE: 20051019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunovant, Inc.
CENTRAL INDEX KEY: 0001764013
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 832771572
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 917-580-3099
MAIL ADDRESS:
STREET 1: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Health Sciences Acquisitions Corp
DATE OF NAME CHANGE: 20190108
4
1
wf-form4_161650380299067.xml
FORM 4
X0306
4
2021-03-19
0
0001764013
Immunovant, Inc.
IMVT
0001341896
Fromkin Andrew J.
320 W 37TH STREET, 6TH FLOOR
NEW YORK
NY
10018
1
0
0
0
Common Stock
2021-03-19
4
A
0
15500
0
A
40200
D
Stock Option (right to buy)
17.0
2021-03-19
4
A
0
23300
0
A
2031-03-19
Common Stock
23300.0
23300
D
Represents the number of shares underlying restricted stock unit awards ("RSUs") granted to the Reporting Person pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in their entirety one year after the date of grant on March 19, 2022, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
The shares underlying the options vest one year after the date of grant on March 19, 2022, subject to the Reporting Person's continuous service to the Issuer as of such date.
/s/ Pamela Yanchik Connealy, attorney-in-fact for Andrew J. Fromkin
2021-03-23